Clinical Trial

Referral of Patients With Biological Abnormalities to an Emergency Department

Study acronym: ORA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Biological testing is an essential part of general medical practice and plays a role in 60% to 70% of diagnoses. 68.5% of prescriptions are written by general practitioners, and one in seven general medical consultations ends with a prescription for biological testing. The study of patient trajectories is a recent emerging topic in the literature, encompassing general concepts. The angle most often taken is medico-economic and focused on specific chronic conditions such as diabetes, cancer, or cardiovascular disease. To our knowledge, there are a number of referrals to emergency departments by general practitioners for patients with biological abnormalities. However, to our knowledge, no study to date has attempted to quantify these specific referrals.
Trial Details
NCT Number NCT07405996
Lead Sponsor Centre Hospitalier Régional Metz-Thionville
Conditions Biological Abnormality, Emergency Department Visit, General Practitioner
Enrollment 5,000 participants
Start Date 2026-02-01
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-12